Hyalubrix® for TEMPORARY SYNOVIAL FLUID REPLACEMENT reducing pain symptoms and improving joint functionality1

Composition

Hyaluronic acid sodium salt (30mg/2mL) obtained by bacterial fermentation from a fraction of high molecular weight1

Available Presentation

Box containing 1 pre-filled syringe sealed in a blister1

Indications

HYALUBRIX® is indicated for the treatment of pain and the improvement of joint functionality in patients affected by degenerative or mechanical arthropathy of the knee, hip, shoulder, ankle and trapeziometacarpal joint1

Dosage & Administration

Cycle of 3 intra-articular injections, at weekly intervals1

Available PRESENTATION

Box containing 1 pre-filled syringe.

Product portfolio

VISCOSUPPLEMENTATION

Medical Devices CE0459.
Read the instructions for use carefully.

References:
1. HYALUBRIX® Patient Information Leaflet

THIS PAGE IS INTENDED ONLY FOR HEALTHCARE PROFESSIONALS

To access this page, please click YES if you are a healthcare professional.
If you are not a healthcare professional, select NO to be redirected.

You are about to leave this website

External content may be subject to different local regulations, product availability may vary by market.